I cowl Stemson Therapeutics (or its founder Dr. Alexey Terskikh, or its CEO Geoff Hamilton) not less than a number of occasions a yr. This firm represents the main hope for a hair multiplication associated hair loss remedy. Among the many highlights:
I now simply replace this complete put up twice a yr fairly than write a separate one every time.
Stemson Therapeutics: 2022 Updates
Replace: December 30, 2022 — Stemson’s Director of Histology and Pathology Dr. Allan Dovigi wrote an attention-grabbing put up on Linkedin that has thus far obtained just one remark. I like his enthusiasm on the velocity of progress in organ regeneration and medication basically. Key quote with slight modifications by me:
“At Stemson Therapeutics we’re rising hair follicles for transplantation in our sufferers with alopecia. We’re eradicating the boundaries to the cell’s genetic packages and switching them again on to permit regeneration of the unique tissues and anatomy. I can observe all of the histology of the regenerated hair follicles, epithelial root sheath round hair shafts, dermal papilla, sebaceous glands and pilar erector muscle. I discover it merely wonderful. Peering by way of my microscope has by no means been extra thrilling.”
It is extremely attention-grabbing that he mentions the essential to hair (however normally ignored) arrector pilli muscle. He predicts that people will be capable to regenerate total organs going ahead, so organ transplants will turn out to be out of date. Word that Stemson at the moment has 25 workers with Linkedin accounts.
Replace: November 20, 2022 — VP Meghan Samberg introduced on Stemson’s iPSC-derived cell remedy method for hair follicle regeneration on the World Congress for Hair Analysis in Australia.
Replace: October 25, 2022 — Attention-grabbing new interview with CEO Geoff Hamilton. Key quote:
“We’re making an attempt to get our first product into clinic, which is an autologous cell therapy-based method to bioengineering hair follicles. It’s in all probability going to be not less than a few extra years earlier than we really feel we’re actually prepared.”
Replace: February 12, 2022 — Joe Tillman and Spencer Kobren have launched three mini-interview movies of Stemson CEO Geoff Hamilton. Elements 2 and three are a very powerful:
Replace: February 1, 2022 — Stemson simply employed Dr. Kapil Bharti and Dr. George Murphy to its scientific advisory board. Each appear to be famend scientists on the planet of regenerative medication and stem cell analysis.
Replace: January 18, 2022 — Mr. Hamilton is roofed in a brand new MIT Know-how article titled: “Going bald? Lab-grown hair cells might be on the way in which.”
Alexey Terskikh and Geoff Hamilton
Replace: December 2021 — Stemson founder Alexey Terskikh simply co-authored an attention-grabbing new paper titled “The rise of induced pluripotent stem cell method to Hair Restoration.”
“Mixed with robotics and automation of the transplantation course of, this novel regenerative medication method is effectively poised to make hair restoration a routine process reasonably priced for everyone who can profit from it. At current, it appears that evidently the era of DP cells by way of the neural crest intermediate has the bottom barrier to enter the medical trials within the subsequent few years.”
Word that Dr. Hamilton additionally gave the keynote tackle on the latest World Hair Loss Summit.
Replace: October 12, 2021 — Presentation on the Alliance for Regenerative Drugs’s “Assembly on the Mesa”:
Replace: September 1, 2021 — Market Data podcast interview with Geoff Hamilton. Make sure that to look at the video in there.
Replace: July 15, 2021 — Stemson coated on the information by native San Diego ABC Information affiliate:
Replace: October 2020 — The ISHRS interviewed Dr. Alexey Terskikh on video.
Replace: September 2020 — Stemson simply bought one other $7.5 million in funding from Allergan and Fortunis Capital. h/t reader “James”. Quote from the CEO of Fortunis:
“Stemson’s novel cell remedy method to deal with hair loss has game-changing potential.”
CEO Geoff Hamilton stated the next:
“Stemson has established the organic and technical constructing blocks that are wanted to unravel the issue of hair loss. A very healing answer is now possible.”
We’ve got heard related reward from various different firm CEOs through the previous decade. So no use in getting hopes raised this early within the course of.
Word that Allergan is concerned within the hair loss world through investments in a big variety of upcoming corporations and applied sciences.
September 14, 2020
Stemson Therapeutics Patent Permitted
Earlier as we speak, Stemson Therapeutics introduced that its cornerstone patent had obtained approval within the US.
This patent (No. 10716808) is titled “Strategies and compositions to modulate hair development”. The know-how is licensed completely from the Sanford Burnham Prebys Medical Discovery Institute.
The method outlined on this patent entails a novel course of to distinguish Induced Pluripotent Stem Cells (iPSC) into dermal papilla cells (DPCs). The latter cells management hair follicle era and hair biking.
Contemplating that Stemson is but to even begin human medical trials, I don’t count on this product to come back to market any time quickly. Nonetheless, the scientific analysis behind this firm’s know-how appears to be stable, and the corporate itself is effectively funded (see additional beneath).
On the corporate’s information web page, final week they introduced the hiring of Dr. Meghan Samberg as Vice President of R&D and Preclinical Growth.
June 27, 2019
Over the last 30 days, now we have obtained optimistic updates from: Aclaris Therapeutics; Dr. Lowry (new firm Pelage Prescription drugs); Follica; Polichem; and Shiseido.
We additionally had a optimistic story from Columbia College (Dr. Angela Christiano) this week that I didn’t cowl. It pertain to previous analysis on JAK-STAT signaling and hair regrowth. I didn’t suppose that we may have a extra inspiring month than now we have simply had on the planet of hair loss remedy analysis.
Stemson Therapeutics has Arrived
Maybe the largest story of the yr is the truth that Stemson Therapeutics is now a actuality, they usually have formally launched their web site. I initially coated this firm in 2018, and mentioned its analysis all the way in which again in 2015.
Furthermore, Stemson has secured a multi-million greenback funding from pharmaceutical large Allergan. In Dr. Alexey Terskikh’s interview with me in 2017, he talked about that the largest factor holding them again was lack of ample funding.
I’ve requested Dr. Terskikh to provide us one other interview quickly and hopefully he’ll settle for. Earlier this month, he instructed me that his lab was given a podium presentation on the ISSCR convention on June twenty seventh. Nonetheless, he didn’t point out the beneath shocking improvement.
Practical Hair Follicles Grown from Stem Cells
Earlier as we speak, San Diego primarily based Sanford Burnham Prebys printed a what appears to be groundbreaking new article: Practical Hair Follicle Grown from Stem Cells. Word that this analysis institute is affiliated with Dr. Terskikh. Extra on their Twitter account.
The breakthrough is as a result of scientists from Sanford Burnham have created natural-looking hair that grows by way of the pores and skin utilizing human induced pluripotent stem cells (iPSCs). Based on the article, this “may revolutionize the hair development business”.
Not like in previous experiments the place new hair development was beneath the pores and skin, haphazard, and disorderly, the present outcomes produced hair rising above the pores and skin in a uniform sample. The breakthrough was achieved by utilizing a biodegradable 3D scaffold that guided hair development by way of the pores and skin in its most well-liked path.
Precise paper is right here. Lead researcher is a Dr. Antonella Pinto.
The present protocol is predicated on mouse epithelial cells mixed with human dermal papilla cells. Nonetheless, the derivation of the epithelial a part of a hair follicle from human iPSCs is at the moment underway within the Terskikh lab. Key quote from the article from as we speak:
“Mixed human iPSC-derived epithelial and dermal papilla cells will allow the era of completely human hair follicles, prepared for allogenic transplantation in people.”
Make sure that to examine the distinction between autologous and allogenic. Stemson Therapeutics has licensed the above know-how from Sanford Burnham.
